Assignee
BIOCAD JOINT STOCK CO
RU·0 granted patents·18 pending applications·0 citations·filing 2017–2023
Top patents by PatentIndex Score
18 records- 0158US2026070980A1Method for treating a t-lymphocyte-mediated diseaseBIOCAD JOINT STOCK CO·Filed 2023·Application pending·0 cites
- 0256US2025282847A1Codon-optimized nucleic acid encoding the fviii-bddBIOCAD JOINT STOCK CO·Filed 2023·Application pending·0 cites
- 0356US2025281640A1Nucleic acid having promoter activity and use thereofBIOCAD JOINT STOCK CO·Filed 2023·Application pending·0 cites
- 0453US2025304707A1Monoclonal antibody or antigen-binding fragment thereof that specifically binds to bcma, and use thereofBIOCAD JOINT STOCK CO·Filed 2023·Application pending·0 cites
- 0552US2025154526A1Method of obtaining a modified adeno-associated virus capsidBIOCAD JOINT STOCK CO·Filed 2022·Application pending·0 cites
- 0652US2024350663A1Isolated modified aav9 capsid protein vp1BIOCAD JOINT STOCK CO·Filed 2022·Application pending·0 cites
- 0752US2025127923A1Isolated modified capsid protein VP1 from adeno-associated virus serotype 5 (AAV5), capsid and vector based thereonBIOCAD JOINT STOCK CO·Filed 2022·Application pending·0 cites
- 0845US2023321220A1Aav5-based vaccine against sars-cov-2BIOCAD JOINT STOCK CO·Filed 2021·Application pending·0 cites
- 0944US2024034764A1Immunocytokine for activating human il-10ra receptor and use thereofBIOCAD JOINT STOCK CO·Filed 2021·Application pending·0 cites
- 1040US2022228134A1Dna-cutting agent based on cas9 protein from the bacterium pasteurella pneumotropicaBIOCAD JOINT STOCK CO·Filed 2020·Application pending·0 cites
- 1138US2022403369A1Use of cas9 protein from the bacterium pasteurella pneumotropicaBIOCAD JOINT STOCK CO·Filed 2020·Application pending·0 cites
- 1238US2023011234A1Immunocytokine comprising heterodymeric protein complex based on il-15/il-15raBIOCAD JOINT STOCK CO·Filed 2020·Application pending·0 cites
- 1336US2023203171A1Aqueous pharmaceutical composition of levilimabBIOCAD JOINT STOCK CO·Filed 2021·Application pending·0 cites
- 1433US2022002692A1DNA cutting means based on Cas9 protein from biotechnologically significant bacterium Clostridium cellulolyticumBIOCAD JOINT STOCK CO·Filed 2019·Application pending·0 cites
- 1533US2022017896A1Dna cutting means based on cas9 protein from defluviimonas sp.BIOCAD JOINT STOCK CO·Filed 2019·Application pending·0 cites
- 1631US2025262153A1Aqueous pharmaceutical composition of anti-pd1 antibody prolgolimab and use thereofBIOCAD JOINT STOCK CO·Filed 2020·Application pending·0 cites
- 1728US2020339544A1Epidermal growth factor receptor inhibitorsBIOCAD JOINT STOCK CO·Filed 2018·Application pending·0 cites
- 1828US2019352276A1Inhibitors of bruton's tyrosine kinaseBIOCAD JOINT STOCK CO·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BIOCAD JOINT STOCK CO files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →